Beyond Air, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
XAIR Nasdaq 3841 www.beyondair.net

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Beyond Air, Inc.

Top Midday Decliners - Jan 14th, 2026 12:10 pm
Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Jan 14th, 2026 6:30 am
Top Midday Gainers - Jan 13th, 2026 11:54 am
BC-Most Active Stocks - Jan 13th, 2026 8:30 am
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership - Jan 13th, 2026 7:28 am
XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership - Jan 13th, 2026 5:30 am
Beyond Air® Appoints Dan Moorhead as Chief Financial Officer - Dec 30th, 2025 5:30 am
Beyond Air® Signs New International LungFit PH® Distribution Agreements, Most Notably in Germany and Brazil - Dec 17th, 2025 5:30 am
Beyond Air® Announces Transition of Chief Financial Officer - Nov 26th, 2025 2:30 pm
Beyond Air Inc (XAIR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... - Nov 10th, 2025 10:02 pm
Beyond Air® Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update - Nov 10th, 2025 2:05 pm
Beyond Air® Secures Up to $32 Million to Accelerate Growth - Nov 5th, 2025 6:00 am
Beyond Air Schedules Second Fiscal Quarter 2026 Financial Results Conference Call and Webcast - Oct 23rd, 2025 6:00 am
Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference - Sep 22nd, 2025 6:00 am
Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds - Sep 8th, 2025 1:55 pm
NeuroNOS Granted FDA Orphan Drug Designation for Glioblastoma, the Most Common and Deadliest Primary Malignant Brain Cancer in Adults - Sep 8th, 2025 6:00 am
Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - Sep 3rd, 2025 6:00 am
Astera Labs Among 3 Leading Growth Companies With Strong Insider Ownership - Aug 27th, 2025 5:40 am
Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan - Aug 20th, 2025 6:00 am
Beyond Air Inc (XAIR) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Expansion ... - Aug 13th, 2025 1:11 am